The next breakthrough in cancer screening is emerging from the convergence of artificial intelligence and canine biology. That’s the thesis behind SpotitEarly, a startup that recently launched in the ...

Startup SpotitEarly is pioneering an innovative early cancer screening test based on breath samples and powered by artificial intelligence and the strong scent detection of trained dogs. SpotitEarly ...

A new cfDNA-based blood test uses AI to detect bladder, prostate, and kidney cancers early, offering a faster, safer, and highly accurate screening option.

In A Nutshell A handheld breath sensor read eight chemicals and flagged lung cancer risk in a 67-person study. Accuracy was 85.71% using the device alone and 92.86% when paired with GC–MS in analysis.

Melanoma remains one of the hardest skin cancers to diagnose because it often mimics harmless moles or lesions. While most ...

A Singaporean research team has developed CAN-Scan (short for Cancer Scan), a next-generation precision oncology platform ...

Making meaningful progress on improving cancer outcomes will require screening to identify more cancers, and at earlier stages, when they may be more treatable. 4,5 Accomplishing this requires a ...

The partnership will expedite the availability of Freenome's tests in markets outside the U.S, according to the company.

The discovery began, as many breakthroughs do, with an observation that didn’t quite make sense. In 1948, two French researchers, Paul Mandel and Pierre Métais, published a little-noticed paper in a ...